1. Home
  2. AIFA vs BYSI Comparison

AIFA vs BYSI Comparison

Compare AIFA & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo All In FutureTech Alliance Inc. Common Stock

AIFA

All In FutureTech Alliance Inc. Common Stock

N/A

Current Price

$3.95

Market Cap

25.1M

ML Signal

N/A

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

N/A

Current Price

$0.69

Market Cap

25.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIFA
BYSI
Founded
N/A
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.1M
25.5M
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
AIFA
BYSI
Price
$3.95
$0.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
88.5K
★ 128.4K
Earning Date
11-23-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $7,655,039.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$49.96
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 20.50
N/A
52 Week Low
$1.52
$0.42
52 Week High
$8.93
$2.44

Technical Indicators

Market Signals
Indicator
AIFA
BYSI
Relative Strength Index (RSI) 43.64 55.00
Support Level $3.59 $0.60
Resistance Level $5.08 $0.85
Average True Range (ATR) 0.38 0.11
MACD -0.09 0.02
Stochastic Oscillator 9.86 56.98

Price Performance

Historical Comparison
AIFA
BYSI

About AIFA All In FutureTech Alliance Inc. Common Stock

All In FutureTech Alliance Inc operates an AI-focused digital infrastructure platform. Its activities include opportunities in AI infrastructure, silicon photonics-enabled computing, fiber-optic network transmission, digital infrastructure services, and technology-related initiatives. The company is also developing the AIFA platform, which is intended to combine AI computing capacity, fiber-optic network infrastructure, AI education, and AI-related applications.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Share on Social Networks: